The STEAP antigens from prostate and melanoma tumor cells also induce cytotoxic and helper T lymphocytes, suggesting that the STEAP protein might be useful as an antitumor peptide vaccine for eradication of STEAP-expressing tumors [7,8]. The gene discussed is STEAP1; the disease is melanoma.